Bulletin
Investor Alert

London Markets Open in:

Lipocine Inc.

NAS: LPCN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 6, 2022, 6:57 p.m.

/zigman2/quotes/202742746/composite

$

0.52

Change

+0.04 +8.85%

Volume

Volume 2,042

Quotes are delayed by 20 min

/zigman2/quotes/202742746/composite

Previous close

$ 0.50

$ 0.48

Change

-0.02 -4.67%

Day low

Day high

$0.45

$0.52

Open

52 week low

52 week high

$0.36

$1.89

Open

John W. Higuchi

John W. Higuchi founded Spriaso LLC. Currently, he is President & Chief Executive Officer at Aciont, Inc. Mr. Higuchi is also on the board of Lipocine, Inc. and Spriaso LLC.

Mr. Higuchi received an undergraduate degree from Hope College and an MBA and a graduate degree from George Washington University.

Transactions

Date Shares Transaction Value
12/31/2020 5,000   Disposition at $1.35 per share. 6,750
12/31/2020 1,700   Disposition at $1.34 per share. 2,278
12/16/2020 3,750   Derivative/Non-derivative trans. at $0 per share. 0
03/17/2020 220,000   Acquisition at $0.32 per share. 70,400
12/29/2017 1,250   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Dr. Mahesh V. Patel
Chairman, President, Chief Executive Officer & CFO
Dr. Anthony DelConte
Chief Medical Director
Dr. Nachiappan Chidambaram
Vice President-Product Development
Mr. John W. Higuchi
Director
Ms. Krista Fogarty
Chief Accounting Officer
Mr. Hans Vitzthum
Head-Investors Relation Contact
Dr. Jill M. Jene
Independent Director
Dr. Spyros Papapetropoulos
Independent Director
Dr. Richard Dana Ono
Independent Director
Mr. Jeffrey Arvin Fink
Independent Director
Link to MarketWatch's Slice.